Your browser doesn't support javascript.
loading
Synthesis and structure-activity relationships for tetrahydroisoquinoline-based inhibitors of Mycobacterium tuberculosis.
Lu, Guo-Liang; Tong, Amy S T; Conole, Daniel; Sutherland, Hamish S; Choi, Peter J; Franzblau, Scott G; Upton, Anna M; Lotlikar, Manisha U; Cooper, Christopher B; Denny, William A; Palmer, Brian D.
Afiliação
  • Lu GL; Auckland Cancer Society Research Centre, School of Medical Sciences, Private Bag 92019, Auckland 1142, New Zealand.
  • Tong AST; Auckland Cancer Society Research Centre, School of Medical Sciences, Private Bag 92019, Auckland 1142, New Zealand.
  • Conole D; Auckland Cancer Society Research Centre, School of Medical Sciences, Private Bag 92019, Auckland 1142, New Zealand.
  • Sutherland HS; Auckland Cancer Society Research Centre, School of Medical Sciences, Private Bag 92019, Auckland 1142, New Zealand.
  • Choi PJ; Auckland Cancer Society Research Centre, School of Medical Sciences, Private Bag 92019, Auckland 1142, New Zealand.
  • Franzblau SG; Institute for Tuberculosis Research, College of Pharmacy, University of Illinois at Chicago, 833 South Wood Street, Chicago, IL 60612, USA.
  • Upton AM; Global Alliance for TB Drug Development, 40 Wall St, NY 10005, USA.
  • Lotlikar MU; Global Alliance for TB Drug Development, 40 Wall St, NY 10005, USA.
  • Cooper CB; Global Alliance for TB Drug Development, 40 Wall St, NY 10005, USA.
  • Denny WA; Auckland Cancer Society Research Centre, School of Medical Sciences, Private Bag 92019, Auckland 1142, New Zealand; Maurice Wilkins Centre, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand. Electronic address: b.denny@auckland.ac.nz.
  • Palmer BD; Auckland Cancer Society Research Centre, School of Medical Sciences, Private Bag 92019, Auckland 1142, New Zealand; Maurice Wilkins Centre, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.
Bioorg Med Chem ; 28(22): 115784, 2020 11 15.
Article em En | MEDLINE | ID: mdl-33007562
ABSTRACT
A series of 5,8-disubstituted tetrahydroisoquinolines were shown to be effective inhibitors of M. tb in culture and modest inhibitors of M. tb ATP synthase. There was a broad general trend of improved potency with higher lipophilicity. Large substituents (e.g., Bn) at the tetrahydroquinoline 5-position were well-tolerated, while N-methylpiperazine was the preferred 8-substituent. Structure-activity relationships for 7-linked side chains showed that the nature of the 7-linking group was important; -CO- and -COCH2- linkers were less effective than -CH2- or -CONH- ones. This suggests that the positioning of a terminal aromatic ring is important for target binding. Selected compounds showed much faster rates of microsomal clearance than did the clinical ATP synthase inhibitor bedaquiline, and modest inhibition of mycobacterial ATP synthase.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Tetra-Hidroisoquinolinas / Mycobacterium tuberculosis / Antituberculosos Idioma: En Revista: Bioorg Med Chem Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Tetra-Hidroisoquinolinas / Mycobacterium tuberculosis / Antituberculosos Idioma: En Revista: Bioorg Med Chem Ano de publicação: 2020 Tipo de documento: Article